These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3087409)

  • 1. Experimental contamination of Minims of fluorescein by Pseudomonas aeruginosa.
    Claoué C
    Br J Ophthalmol; 1986 Jul; 70(7):507-9. PubMed ID: 3087409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential bacterial contamination in fluorescein-anesthetic solutions.
    Duffner LR; Pflugfelder SC; Mandelbaum S; Childress LL
    Am J Ophthalmol; 1990 Aug; 110(2):199-202. PubMed ID: 2116089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reuse of opthalmic Minims: an unacceptable cross-infection risk?
    Rautenbach P; Wilson A; Gouws P
    Eye (Lond); 2010 Jan; 24(1):50-2. PubMed ID: 19247391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contamination of contact-lens-related sources with Pseudomonas aeruginosa.
    Micallef C; Cuschieri P; Bonnici MR
    Ophthalmologica; 2000; 214(5):324-31. PubMed ID: 10965245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contamination of single-use Minims eye drops by multiple use in clinics.
    Qureshi MA; Wong R; Robbie SJ; Qureshi KM; Rowe C; Leach J
    J Hosp Infect; 2006 Feb; 62(2):245-7. PubMed ID: 16289460
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluress, fluorescein and benoxinate: recovery from bacterial contamination.
    Yolton DP; German CJ
    J Am Optom Assoc; 1980 May; 51(5):471-4. PubMed ID: 6771320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reuse of ophthalmic minims: an unacceptable cross-infection risk?
    Yap YC; Smith M; Byles D
    Eye (Lond); 2010 Aug; 24(8):1421-2. PubMed ID: 20508657
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential bacterial contamination of eyedrops used for tonometry.
    Palmberg R; Gutierrez YS; Miller D; Feuer WJ; Anderson DR
    Am J Ophthalmol; 1994 May; 117(5):578-82. PubMed ID: 8172262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contamination of fluorescein solutions; with special reference to pseudomonas aeruginosa (bacillus pyocyaneus).
    VAUGH DG
    Am J Ophthalmol; 1955 Jan; 39(1):55-61. PubMed ID: 13218114
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservation of fluorescein solutions against contamination with Pseudomonas aeruginosa.
    Richards RM; Suwanprakorn P; Neawbanij S; Surasdikul N
    J Pharm Pharmacol; 1969 Oct; 21(10):681-6. PubMed ID: 4390611
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid diagnosis of Pseudomonas aeruginosa infection by demonstration of pyocyanin & fluorescein.
    Subramaniam L; Shriniwas
    Indian J Med Res; 1985 Jun; 81():561-6. PubMed ID: 3932199
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple withdrawals from single-use vials: a study on sterility.
    Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
    Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa contamination of liquid antacids: a survey.
    Robinson EP
    J Pharm Sci; 1971 Apr; 60(4):604-5. PubMed ID: 5001880
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contamination of hypertonic saline solutions in use by cystic fibrosis patients in Israel.
    Peled O; Kalamaro V; Kerem E; Shoseyov D; Blau H; Efrati O; Block C
    J Cyst Fibros; 2014 Sep; 13(5):550-6. PubMed ID: 24484849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of drugs contaminated with microorganisms].
    Stavri N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(2):273-7. PubMed ID: 828290
    [No Abstract]   [Full Text] [Related]  

  • 17. Contamination of hospital tap water: the survival and persistence of Pseudomonas aeruginosa on conventional and 'antimicrobial' outlet fittings.
    Hutchins CF; Moore G; Thompson KA; Webb J; Walker JT
    J Hosp Infect; 2017 Oct; 97(2):156-161. PubMed ID: 28602704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of a pseudomonas corneal ulcer in an occasional use daily disposable contact lens wearer.
    Munneke R; Lash SC; Prendiville C
    Eye Contact Lens; 2006 Mar; 32(2):94-5. PubMed ID: 16538131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.